Safety Study of AP24534 to Treat Chronic Myelogenous Leukemia (CML) and Other Hematological Malignancies

This study is ongoing, but not recruiting participants.

Study NCT00660920 Information provided by Ariad Pharmaceuticals

First Received: April 15, 2008 Last Updated: September 14, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	July 2013
Estimated Primary Completion Date:	April 2012 (Final data collection date for primary outcome measure)